Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 31 May 23 424B3 Prospectus supplement
- 16 Dec 22 424B3 Prospectus supplement
- 16 Dec 22 EFFECT Notice of effectiveness
-
9 Dec 22 S-1 IPO registration
NBY similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference, in the Prospectus constituting a part of this Registration Statement on Form S-1, of our report dated March 29, 2022 relating to the consolidated financial statements of NovaBay Pharmaceuticals, Inc. included in its Annual Report on Form 10-K for the year ended December 31, 2021. We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC | |
San Francisco, California | |
December 9, 2022 |